Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric Antigen Receptor T-cell) treatments.

The company is hoping longer follow-up will deliver enough positive trial data on its CRISPR T-cell therapies for blood ...

USC researchers have developed an innovative type of cancer-fighting immune cell, the EchoBack CAR T-cell, that uses focused ...

Over 80% of patients with relapsed/refractory multiple myeloma responded to anti-GPRC5D CAR T-cell therapy after failure of anti-BCMA CAR T-cell therapy. The investigational therapy showed superior ...

The FDA granted breakthrough therapy designation to an autologous CAR-T cell therapy for pediatric patients with diffuse ...

NOVEL lymph-node-inspired hydrogels enhance CAR T cell activation and proliferation by 50%, offering a more efficient and ...

Liso-Cel is a type of CAR T-cell therapy — a revolutionary approach that uses a patient's own immune cells to fight cancer.

A downtown street project in Mandan is drawing sharp criticism from business owners who say it could drive customers away and ...

The MINI Convertible family is all-new for a fourth generation in 2025, with three distinct models for North America: Cooper ...

For many golf patrons who are lucky enough to land tickets to the Masters, it can be the experience of the lifetime.

In recent years, market players have been actively pursuing collaborations and partnerships with biotechnology and pharmaceutical companies to accelerate the development of next-generation CAR T-cell ...

A combination of Novartis’ 'next generation' CAR-T drug CTL119 with Janssen and AbbVie's Imbruvica has cleared all signs of chronic lymphocytic leukaemia from eight out of nine patients in a ...